Essentials Risk‐stratification often fails to predict clinical deterioration in pulmonary embolism (PE). First‐ever high‐throughput metabolomics analysis of risk‐stratified PE patients. Changes in circulating metabolites reflect a compromised energy metabolism in… Click to show full abstract
Essentials Risk‐stratification often fails to predict clinical deterioration in pulmonary embolism (PE). First‐ever high‐throughput metabolomics analysis of risk‐stratified PE patients. Changes in circulating metabolites reflect a compromised energy metabolism in PE. Metabolites play a key role in the pathophysiology and risk stratification of PE.
               
Click one of the above tabs to view related content.